Douglas B. Given - 07 Jan 2022 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/ Douglass Given
Issuer symbol
ARWR
Transactions as of
07 Jan 2022
Transactions value $
$0
Form type
4
Date filed
07 Jan 2022, 19:10
Previous filing
29 Dec 2021
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $0 +6.4K +5.83% $0.00 116K 07 Jan 2022 Direct F1
holding ARWR Common Stock 13.9K 07 Jan 2022 By Trust F2
holding ARWR Common Stock 12.5K 07 Jan 2022 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
F2 Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
F3 Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.